76 research outputs found
Attractive Riesz potentials acting on hard spheres
In this paper we introduce a model for hard spheres interacting through
attractive Riesz type potentials, and we study its thermodynamic limit. We show
that the tail energy enforces optimal packing and round macroscopic shapes
Insights into Myocardial Perfusion PET Imaging: the Coronary Flow Capacity
Purpose of Review The present work summarizes the clinical relevance of coronary flow capacity (CFC) with an eye on
future perspectives.
Recent findings CFC concept has been recently introduced providing a comprehensive framework for coronary physiology
evaluation.
Summary It has been widely demonstrated that coronary artery disease (CAD) is a complex disease with a multifactorial
etiology resulting from different pathogenic mechanisms. Cardiac positron emission tomography (PET) currently represents
the gold standard for CAD assessment, providing absolute myocardial perfusion data including coronary flow reserve (CFR),
calculated as the ratio of hyperemic to rest absolute myocardial blood flows. CFC can be obtained from dynamic PET images
by plotting the primary stress perfusion data and CFR values for each pixel on a graph of predefined exact ranges. The routine
evaluation of this parameter may add diagnostic and prognostic value to clinical and conventional imaging data
Cardiac involvement in Erdheim- Chester disease: MRI findings and literature revision
: Erdheim-Chester disease (ECD) is a rare form of non-Langerhans cell histiocytosis, characterized by the involvement of several organs. The lesions may be skeletal or extra-skeletal: in particular, long bones, skin, lungs, and the cardiovascular and the central nervous systems can be affected. In this report, we describe a case of a 34-year-old man, who came to our observation with symptomatic ECD, for a correct assessment of the degree of cardiac involvement through magnetic resonance imaging (MRI)
Cardiac hybrid imaging: novel tracers for novel targets
Non-invasive cardiac imaging has explored enormous advances in the last few decades. In particular, hybrid imaging represents the fusion of information from multiple imaging modalities, allowing to provide a more comprehensive dataset compared to traditional imaging techniques in patients with cardiovascular diseases. The complementary anatomical, functional and molecular information provided by hybrid systems are able to simplify the evaluation procedure of various pathologies in a routine clinical setting. The diagnostic capability of hybrid imaging modalities can be further enhanced by introducing novel and specific imaging biomarkers. The aim of this review is to cover the most recent advancements in radiotracers development for SPECT/CT, PET/CT, and PET/MRI for cardiovascular diseases
Tracers for Cardiac Imaging: Targeting the Future of Viable Myocardium
Ischemic heart disease is the leading cause of mortality worldwide. In this context, myocar- dial viability is defined as the amount of myocardium that, despite contractile dysfunction, maintains metabolic and electrical function, having the potential for functional enhancement upon revascular- ization. Recent advances have improved methods to detect myocardial viability. The current paper summarizes the pathophysiological basis of the current methods used to detect myocardial viability in light of the advancements in the development of new radiotracers for cardiac imaging
Advanced CMR Techniques in Anderson-Fabry Disease: State of the Art
Anderson-Fabry disease (AFD) is a rare multisystem X-linked lysosomal storage disorder caused by α-galactosidase A enzyme deficiency. Long-term cardiac involvement in AFD results in left ventricular hypertrophy and myocardial fibrosis, inducing several complications, mainly
arrhythmias, valvular dysfunction, and coronary artery disease. Cardiac magnetic resonance (CMR) represents the predominant noninvasive imaging modality for the assessment of cardiac involvement in the AFD, being able to comprehensively assess cardiac regional anatomy, ventricular function as well as to provide tissue characterization. This review aims to explore the role of the most advanced CMR techniques, such as myocardial strain, T1 and T2 mapping, perfusion and hybrid imaging, as diagnostic and prognostic biomarkers
Quantification of Coronary Artery Atherosclerotic Burden and Muscle Mass: Exploratory Comparison of Two Freely Available Software Programs
Abstract: Coronary artery calcification and sarcopenia may have a relevant prognostic impact in oncological and nonâoncological patients. The use of freeware software is promising for quantitative evaluation of these parameters after wholeâbody positron emission tomography (PET)/computed tomography (CT) and might be useful for oneâstop shop risk stratification without additional radiation ionizing burden and further charges to health care costs. In this study, we compared two semiautomatic freeware software tools (Horos Medical Image software and LIFEx) for the assessment of coronary artery calcium (CAC) score and muscle mass in 40 patients undergoing wholeâbody PET/CT. The muscle areas obtained by the two software programs were comparable, showing high correlation with Linâs concordance coefficient (0.9997; 95% confidence intervals: 0.9995â0.9999) and very good agreement with BlandâAltman analysis (mean difference = 0.41 cm2, lower limit = â1.06 cm2, upper limit = 1.89) was also found. For CAC score, Linâs concordance correlation coefficient was 0.9976 (95% confidence intervals: 0.9965â0.9984) and in a BlandâAltman analysis an increasing mean difference from 8 to 78 by the mean values (intercept = â0.050; slope = 0.054; p < 0.001) was observed, with a slight overestimation of Horos CAC score as compared to LIFEx, likely due to a different calculation method of the CAC score, with the ROI being equal for the two software programs. Our results demonstrated that offâline analysis performed with freeware software may allow a comprehensive evaluation of the oncological patient, making available the evaluation of parameters, such as muscle mass and calcium score, that may be relevant for the staging and prognostic stratification of these patients, beside standard data obtained by PET/CT imaging. For this purpose, the Horos and LIFEx software seem to be interchangeable
Role of serial cardiac 18F-FDG PET-MRI in Anderson-Fabry disease: a pilot study
Aim: We investigated the value of serial cardiac 18F-FDG PET-MRI in AndersonâFabry disease (AFD) and the potential relationship of imaging results with FASTEX score.
Methods and results: Thirteen AFD patients underwent cardiac 18F-FDG PET-MRI at baseline and follow-up. Coefficient of variation (COV) of FDG uptake and FASTEX score were assessed. At baseline, 9 patients were enzyme replacement therapy (ERT) naïve and 4 patients were under treatment. Two patients presented a FASTEX score of 0 indicating stable disease and did not show any imaging abnormality at baseline and follow-up PET-MRI. Eleven patients had a FASTEX score > 20% indicating disease worsening. Four of these patients without late gadolinium enhancement (LGE) and with normal COV at baseline and follow-up had a FASTEX score of 35%. Three patients without LGE and with abnormal COV at baseline and follow-up had a FASTEX score ranging from 30 to 70%. Three patients with LGE and abnormal COV at baseline and follow-up had a FASTEX score between 35 and 75%. Finally, one patient with LGE and normal COV had a FASTEX score of 100%. Of the 12 patients on ERT at follow-up, FASTEX score was significantly higher in those 4 showing irreversible cardiac injury at baseline compared to 8 with negative LGE (66 ± 24 vs. 32 ± 21, p = 0.03).
Conclusion: 18F-FDG PET-MRI may be effective to monitor cardiac involvement in AFD
Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review
Rectal cancer (RC) is one of the most common tumours worldwide in both males and females, with significant morbidity and mortality rates, and it accounts for approximately one-third of colorectal cancers (CRCs). Magnetic resonance imaging (MRI) has been demonstrated to be accurate in evaluating the tumour location and stage, mucin content, invasion depth, lymph node (LN) metastasis, extramural vascular invasion (EMVI), and involvement of the mesorectal fascia (MRF). However, these features alone remain insufficient to precisely guide treatment decisions. Therefore, new imaging biomarkers are necessary to define tumour characteristics for staging and restaging patients with RC. During the last decades, RC evaluation via MRI-based radiomics and artificial intelligence (AI) tools has been a research hotspot. The aim of this review was to summarise the achievement of MRI-based radiomics and AI for the evaluation of staging, response to therapy, genotyping, prediction of high-risk factors, and prognosis in the field of RC. Moreover, future challenges and limitations of these tools that need to be solved to favour the transition from academic research to the clinical setting will be discussed
- âŠ